Cspc Pharmaceutical | 1093 - Betriebsaufwand

Aktienkurs
8.80
Täglich Wechseln
-0.18 -2.00%
Monatlich
-5.17%
Jährlich
45.70%
Q2 Prognose
8.80




Betriebsaufwand Veränderung Datum
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 1.19M 148K 2025-09
Avita Medical AUD 28.02M 1.55M 2025-12
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Ionis Pharmaceuticals USD 418M 101.1M 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
Jiangsu Hengrui CNY 5.52B 604.29M 2026-03
Kangmei Pharma CNY 1.39B 144.29M 2025-09
Moderna USD 1.54B 259M 2025-12
Organon & Co USD 906M 362M 2025-09
Revvity USD 626.22M 25.62M 2025-12
Sh Fosun Pharma CNY 11.3B 2.18B 2025-12
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Tectonic Therapeutic USD 21.52M 374K 2025-12
Viatris USD 3.86B 335.7M 2025-12
Wuxi Apptec CNY 7.84B 354.28M 2025-12
Xeris Pharmaceuticals USD 69.03M 1.38M 2025-12
Zz Pientze Pharmaceu CNY 1.55B 129.66M 2025-09